ANI Pharmaceuticals to Present at Upcoming November Investor Conferences
ANI Pharmaceuticals (ANIP) will participate in investor conference presentations and fireside chats on November 10 and November 17, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
ANI Pharmaceuticals (ANIP) will participate in investor conference presentations and fireside chats on November 10 and November 17, 2026.
The Guggenheim Healthcare Innovation Conference session is at 1:30 p.m. ET; the Jefferies Global Healthcare Conference in London session is at 9:30 a.m. GMT, respectively. CEO Nikhil Lalwani and executive leadership members will participate. Live and archived webcasts will be available on the company’s investor website.
Details
News Market Reaction – ANIP
On Nov 3, the day this news came out, ANIP closed 2.28% above the previous close.
Data tracked by StockTitan Argus for the Nov 3 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PRINCETON, N.J., Nov. 03, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that Nikhil Lalwani, President and Chief Executive Officer, along with members of the Company’s executive leadership team, will participate in presentations and fireside chats at the following upcoming investor conferences:
| Event | Guggenheim 3rd Annual Healthcare Innovation Conference |
| Date | Tuesday, November 10, 2026 |
| Time | 1:30 p.m. ET |
| Webcast | Click here |
| Event | 2026 Jefferies Global Healthcare Conference in London |
| Date | Tuesday, November 17, 2026 |
| Time | 9:30 a.m. GMT |
| Webcast | Click here |
The live and archived webcasts will also be accessible from the Company’s website at www.anipharmaceuticals.com, in the Investors section under Events and Presentations.
About ANI
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Brands business. For more information, visit https://www.anipharmaceuticals.com.
Investor Relations:
Irina Koffler, Vice President, Investor Relations
T: 917-734-7387
E: Irina.koffler@anipharmaceuticals.com
Media Relations:
Argot Partners
T: 212-600-1494
E: ani@argotpartners.com
SOURCE: ANI Pharmaceuticals, Inc.
